1. Home
  2. ENOV vs NGVT Comparison

ENOV vs NGVT Comparison

Compare ENOV & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • NGVT
  • Stock Information
  • Founded
  • ENOV 1995
  • NGVT 1964
  • Country
  • ENOV United States
  • NGVT United States
  • Employees
  • ENOV N/A
  • NGVT N/A
  • Industry
  • ENOV Fluid Controls
  • NGVT Major Chemicals
  • Sector
  • ENOV Industrials
  • NGVT Industrials
  • Exchange
  • ENOV Nasdaq
  • NGVT Nasdaq
  • Market Cap
  • ENOV 1.8B
  • NGVT 2.1B
  • IPO Year
  • ENOV 2008
  • NGVT N/A
  • Fundamental
  • Price
  • ENOV $31.99
  • NGVT $53.76
  • Analyst Decision
  • ENOV Strong Buy
  • NGVT Buy
  • Analyst Count
  • ENOV 6
  • NGVT 2
  • Target Price
  • ENOV $51.00
  • NGVT $58.00
  • AVG Volume (30 Days)
  • ENOV 598.6K
  • NGVT 175.8K
  • Earning Date
  • ENOV 11-06-2025
  • NGVT 11-05-2025
  • Dividend Yield
  • ENOV N/A
  • NGVT N/A
  • EPS Growth
  • ENOV N/A
  • NGVT N/A
  • EPS
  • ENOV N/A
  • NGVT N/A
  • Revenue
  • ENOV $2,189,576,000.00
  • NGVT $1,324,800,000.00
  • Revenue This Year
  • ENOV $9.13
  • NGVT N/A
  • Revenue Next Year
  • ENOV $6.39
  • NGVT $2.77
  • P/E Ratio
  • ENOV N/A
  • NGVT N/A
  • Revenue Growth
  • ENOV 14.40
  • NGVT N/A
  • 52 Week Low
  • ENOV $25.47
  • NGVT $28.49
  • 52 Week High
  • ENOV $49.83
  • NGVT $60.77
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 52.16
  • NGVT 42.77
  • Support Level
  • ENOV $29.00
  • NGVT $53.81
  • Resistance Level
  • ENOV $34.28
  • NGVT $57.47
  • Average True Range (ATR)
  • ENOV 1.13
  • NGVT 1.59
  • MACD
  • ENOV 0.11
  • NGVT -0.01
  • Stochastic Oscillator
  • ENOV 56.63
  • NGVT 24.13

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Share on Social Networks: